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Abstract
The glycoprotein H (gH)/gL heterodimer is crucial for herpesvirus membrane fusion. Yet how it functions is not well
understood. The Murid Herpesvirus-4 gH, like that of other herpesviruses, adopts its normal virion conformation by
associating with gL. However, gH switched back to a gL-independent conformation after virion endocytosis. This switch
coincided with a conformation switch in gB and with capsid release. Virions lacking gL constitutively expressed the down-
stream form of gH, prematurely switched gB to its down-stream form, and showed premature capsid release with poor
infectivity. These data argue that gL plays a key role in regulating a gH and gB functional switch from cell binding to
membrane fusion.
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Introduction
Enveloped viruses deliver their capsids to the cytoplasm by
fusing with either the plasma membrane or the limiting
membranes of endocytic vesicles. Many viruses use a single
glycoprotein for both binding and membrane fusion. Herpesvi-
ruses, by contrast, use at least four [1,2]; their entry mechanisms
are implicitly more complex. Proteins specific to individual
herpesviruses can modulate fusion, for example the Herpes
simplex virus gD brings together gB and gH/gL after ligand
engagement to trigger fusion [3,4], and the Epstein-Barr virus
gp42 binds gH/gL to promote B cell over epithelial cell fusion [5].
But the core fusion machinery of gB, gH and gL is conserved.
Down-stream fusion events are therefore likely to be common to
all herpesviruses.
We have analyzed gB and gH/gL using the MHV-68 isolate of
Murid Herpesvirus-4 (MuHV-4) [6–8]. This gamma-herpesvirus
has subtle differences from the more extensively studied Herpes
simplex virus, for example it lacks an obvious homolog of gD and
fuses after endocytosis rather than at the plasma membrane [9].
Nevertheless, the conservation of gB and gH/gL implies that they
operate similarly in these and other herpesviruses once the fusion
mechanism is engaged. Incoming MuHV-4 virions first bind to cell
surface heparan sulphate proteoglycans via gH/gL or gp70 [10,11].
Gp150 displacement then allows further, heparan sulphate-
independent binding, probably via gB [10,12]. Virions are
endocytosed and transported to LAMP-1
+ late endosomes [13];
membrane fusion then releases virion capsids into the cytoplasm;
and these move to the nuclear margin for genome delivery [13].
Both gB and gH have hydrophobic loops that could participate
directly in fusion [14,15]. Structural analysis of the Herpes simplex
virus gB has [14] shown how these might be made available.
Comparison with the Vesicular stomatitis virus glycoprotein G
[16] suggests that the crystallized form of gB, with its distinct
crown formed mainly from C-terminal domains, is a down-stream
form. Consistent with this, the Murid Herpesvirus-4 (MuHV-4) gB
switches during entry from having readily accessible N-terminal
epitopes and poorly accessible epitopes involving C-terminal
domains to the converse [13]. The N-terminal domains are
involved in cell binding [10]. Thus, gB on extracellular MuHV-4
virions adopts a conformation that allows cell-binding, then
following endocytosis undergoes a pH-dependent conformation
switch that leads to membrane fusion. Whether this conformation
change itself drives membrane fusion, as for Vesicular stomatitis
virus, or whether further conformation changes are required along
the lines suggested by Heldwein et al. [14], remains unclear.
While quite a lot is known about gB, much less is known about
gH/gL. Understanding gH/gL therefore presents the major
obstacle to understanding herpesvirus entry. Unlike gH, gL lacks
obvious fusion loops or a trans-membrane domain. Its contribu-
tion to membrane fusion is therefore likely to be indirect. So far,
gL has been defined only as a chaperone for gH [9,17,18]. Some
herpesviruses need gL to get gH into virions [17,18]; Pseudor-
abiesvirus does not, but remains non-infectious without gL [19];
MuHV-4 lacking gL both incorporates gH into virions and
remains infectious [20]. These differences may reflect how gB and
gH associate. The Herpes simplex virus gB and gH come together
only when gD is ligated [3,4], so their interaction is likely to
involve extracellular domains; for gH, this would imply a
requirement for gL. The MuHV-4 gB and gH associate
constitutively and independently of gL, probably via an intra-
membrane interaction [21]. Because MuHV-4 does not require
gH/gL for viability, it provides a convenient tool with which to
explore gL-dependent down-stream events in viral entry.
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2 MuHV-4 virions do show some attenuation relative to the
wild-type. One deficit is reduced binding to BHK-21 fibroblasts
[20]. This reflects that gH/gL binds to GAGs, whereas gH alone
does not [11]. However, gL-deficient virions infect NMuMG
epithelial poorly even though they bind to them quite well [20]. gL
must therefore have another function that is important for
NMuMG cell infection. Here we identify an entry-associated
conformation change in gH that was consistent with gL
dissociation in late endosomes, the site of MuHV-4 capsid release.
When virions lacked gL, gH and gB both adopted their down-
stream forms prematurely. This led to premature capsid release
and poor infectivity. An important function of gL is therefore to
regulate the gB and gH conformation changes that lead to viral
membrane fusion.
Results
The MuHV-4 gH changes conformation after endocytosis
MuHV-4 infects adherent cells via endocytosis. Capsid release is
pH-dependent and occurs when virions reach the late endosomes/
lysosomes marked by lysosome-associated membrane protein-1
(LAMP-1) [13]. Capsid release is associated with a conformation
change in gB. To test whether gH also changes, we examined its
antigenicity before and after endocytosis (Fig. 1) using mAbs that
distinguish gL-dependent and gL-independent gH conformations
[9,20]. The gH on wild-type virions is mostly bound to gL [20].
MAbs requiring both gH and gL for recognition, such as 7E5 and
T2C12, accordingly stained incoming virions strongly at the cell
surface (Fig. 1A). However, this staining was lost after endocytosis.
In contrast, the gH-only-specific mAb MG-9B10 [20] gave weak
staining at the cell surface and much stronger staining after
endocytosis. Other gH-only-specific mAbs such as MG-1A2 and
MG-2E6 [20] gave similar results to MG-9B10. The correspond-
ing gH and gH/gL epitopes are all conformational, as the mAbs
do not recognize denatured virions, and can all be expressed in the
absence of other virion proteins on transfected cells. Therefore gH
did not appear to be denatured or disguised, but rather switched
from a gL-dependent to a gL-independent conformation.
The MuHV-4 gH changes conformation in LAMP-1
+
endosomes
The disappearance of gH/gL epitopes coincided with virions
reaching LAMP-1
+ late endosomes; any residual gH/gL-specific
staining after incubation at 37uC was confined to LAMP-1
2
compartments (Fig. 1B, arrow). In contrast, gH-only staining co-
localized with LAMP-1. Most virion gH therefore switched from
gH/gL on extracellular virions to gH-only in late endosomes.
Figure 1. Glycoprotein H changes its antigenicity after endocytosis. A. NMuMG cells were exposed to MuHV-4 virions (3 p.f.u./cell, 2 h, 4uC),
washed63 with PBS and either fixed immediately (4uC) or after a further 2 h incubation at 37uC (37uC). The cells were then stained for gH (MG-9B10),
gH/gL (T2C12, 7E5) or gN (3F7) as an invariant control. Glycoprotein staining is green; nuclei are counterstained with DAPI (blue). The data are
representative of 5 experiments, and similar results were obtained with 3 other gH-specific/gH/gL-specific mAb pairs. Single cells are shown for
optimal resolution. In this as in subsequent figures, each individual cell is fully representative of at least 75% of the total examined (n.100). B. Cells
were infected as in A, then stained for LAMP-1 (red) plus either gH (mAb MG-9B10) or gH/gL (mAb 7E5) (green). Co-localization is yellow. The arrow
indicates residual gH/gL staining that does not colocalize with LAMP-1.
doi:10.1371/journal.pone.0002811.g001
MuHV-4 gH
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and capsid release all coincided in time and place.
The gH/gL conformation changes are pH-dependent
The localization of the gH conformation switch to LAMP-1
+
late endosomes suggested that it required low pH. This was
confirmed with inhibitors of lysosomal acidification (Fig. 2A). After
incubating virions with cells at 37uC without drugs, gH-only
staining predominated over gH/gL. But when the cells were
treated with bafilomycin or Concanamycin A, although virions
were still endocytosed and transported to LAMP-1
+ endosomes,
gH/gL staining was preserved and gH-only staining correspond-
ingly reduced. In particular, gH/gL staining now co-localized with
LAMP-1, something never observed without drug treatment.
Blocking endocytosis with chlorpromazine also blocked the gH
conformation change, as did ammonium chloride treatment
(Fig. 2B). Although the latter classically blocks endosomal
acidification, it also blocked MuHV-4 endocytosis. Such an effect
has been observed before [22]. Thus, in contrast to bafilomycin
and Concanamycin A, the effect of NH4Cl could not be attributed
to a rise in endosomal pH. However, it seemed clear from the
bafilomycin and Concanamycin A treatments that the MuHV-4
gH conformation switch required virion delivery to low pH
endosomes rather than just endocytosis.
A lack of gL causes a post-binding entry deficit
The apparent dissociation of gL from gH during MuHV-4 entry
suggested that the gH-only conformation is functionally important,
and therefore that gL has a more complicated role than merely
folding gH for cell binding. One prediction of this would be that
removing gL has consequences for post-binding entry events. We
looked for evidence of a gL-dependent post-binding infection
deficit by binding gL
+ and gL
2 virions to NMuMG cells for 3 h,
washing off any unbound virions, and then comparing the initial
virion uptake with subsequent viral eGFP expression (Fig. 3). We
compared first a gL
2 mutant with the wild-type, and then an
independent gL
2 mutant with its revertant. Cell binding was
similar between the gL
2 and gL
+ viruses, but virus-driven eGFP
expression was markedly different. After 6 h, eGFP expression by
the gL
2 viruses was virtually undetectable: for an equivalent level
of binding, the infectivity of gL
+ MuHV-4 for NMuMG cells at
6 h was at least 100 times greater than that of gL
2 mutants. Even
after 18 h, gL
+ viruses showed at least 10-fold more eGFP
expression for an equivalent level of binding. gL
2 virions therefore
showed a marked post-binding infection deficit in NMuMG cells.
gL
2 virions show premature capsid release
We tracked the entry of gL
2 virions into NMuMG cells by
immunofluorescence (Fig. 4A). MAb MG-12B8 recognizes an
ORF65 capsid epitope that is inaccessible on virions until they
have uncoated [23]. There was accordingly no MG-12B8 staining
of either wild-type or gL
2 virions after binding to NMuMG cells at
4uC (Fig. 4A). After incubation at 37uC, the capsids of wild-type
virions had become visible and reached the nuclear margin. In
contrast, gL
2 virion capsids, although accessible, remained
scattered throughout the cytoplasm. The same abnormal capsid
Figure 2. The gH/gL conformation change is pH-dependent. A.
MuHV-4 virions were bound to NMuMG cells (2 h, 4uC) with or without
bafilomycin (500 nM) or concanamycin A (1 mM). The cells were then
washed in PBS to remove unbound virions, further incubated with or
without drugs (2 h, 37uC), fixed, permeabilized and stained for gH or
gH/gL plus LAMP-1. Nuclei were counterstained with DAPI. B. In a
similar experiment, MuHV-4 virions were bound to NMuMG cells (2 h,
4uC) with or without NH4Cl (100 mM) or chlorpromazine (3 mg/ml).
Unbound virus was removed by PBS wash and the cells incubated
further (37uC, 2 h), again with or without drug treatment, before fixing,
permeabilizing and staining for gH or gH/gL. Although NH4Cl is
generally considered to block endosomal acidification, here it also
seemed to block virion endocytosis.
doi:10.1371/journal.pone.0002811.g002
MuHV-4 gH
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different gL mutants, but not for their revertants or the wild-type
(Fig. 4B). Since capsids are normally released only from
perinuclear late endosomes, the gL
2 virions must have released
their capsids prematurely in the entry pathway.
The glycoproteins of gL
2 virions were still internalized rather
than incorporated into the plasma membrane. Surprisingly,
infection by gL
2 virions also remained at least as sensitive to
inhibitors of endocytosis and lysosomal acidification as that of the
wild-type or gL
+ revertants (Fig. 5). This may reflect that low pH
has a wider importance for MuHV-4 entry than switching the
conformation of virion glycoproteins. For example, it could be
required to reveal a key cellular ligand. Simply exposing cell-
bound virions to low pH triggered the gH conformation change at
best poorly (data not shown). We have observed this also for gB
[13]. Therefore the MuHV-4 gH and gB conformation switches
were not simply pH-dependent as for Vesicular stomatitis virus
glycoprotein G [16]: other features of the endosome environment
were required. Nevertheless, low pH was essential for efficient gH
and gB switching and for capsid release.
It is important to note that most gL
2 virions were non-infectious
(Fig. 3). Therefore most of the prematurely capsids of gL
2 virions
were destined not to reach nuclear pores. What gL
2 infection
there was may have depended on a few of these capsids being
transported, or on some virions still managing to follow the normal
pathway to late endosomes without premature membrane fusion.
gL
2 virions show gB conformational instability
Since MuHV-4 membrane fusion, as defined by capsid release,
is associated with a conformation change in gB [13], we further
analyzed incoming gL
2 virions for changes in gB antigenicity. The
gB of wild-type virions changed from BN-1A7
+MG-1A12
2 (pre-
fusion) at the cell surface to BN-1A7
2MG-1A12
+ (post-fusion) in
late endosomes (Fig. 4A). gL
2 virions attached to the plasma
membrane were also BN-1A7
+MG-1A12
2. However, unlike the
wild-type, some acquired the MG-1A12 epitope before reaching
LAMP-1
+ endosomes. A premature gB switch to MG-1A12
+ was
also observed for gL
2 virions in NIH-3T3 cells (Fig. 6). The gL-
dependent conformational instability of gB was not marked, as
considerable BN-1A7 staining remained outside LAMP-1
+
endosomes. Nevertheless, as judged by capsid release this degree
of instability was functionally important.
Flow cytometry of infected BHK-21 cells provided further
evidence of gB conformational instability in the absence of gL
Figure 3. gL
2 virions show a post-binding deficit in NMuMG cell infection. NMuMG cells were exposed to gL
+ or gL
2 MuHV-4 virions (3 h,
37uC), then washed63 in PBS. Equivalent samples were then either fixed, permeabilized and stained for gN with mAb 3F7 to determine virion uptake
by flow cytometry; or incubated for a further 3 h or 15 h, after which viral eGFP expression was assayed by flow cytometry of intact cells. Each point
shows the result for 10,000 cells. Equivalent results - the infectivity of gL
2 viruses was ,1% that of gL
+ viruses for an equivalent level of cell binding -
were obtained in a repeat experiment.
doi:10.1371/journal.pone.0002811.g003
MuHV-4 gH
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2 virions show altered glycoprotein and capsid distributions and gB conformation changes. A. NMuMG cells were exposed
to wild-type or gL
2 virions (2 h, 4uC, 3 p.f.u./cell) then washed 63 in PBS and either fixed immediately (4uC) or first incubated (2 h, 37uC) to allow
virion endocytosis (37uC). The cells were then permeabilized and stained for LAMP-1 plus MuHV-4 capsid or glycoprotein antigens as shown. Nuclei
were counterstained with DAPI. Colocalization appears as yellow in the merged images. Equivalent data were obtained in 3 further experiments. B.
MCCD epithelial cells were incubated with a range of different gL
2 or gL
+ viruses (2 h, 4uC, 3 p.f.u./cell), then washed 63 with PBS and incubated
further (2 h, 37uC) to allow virion endocytosis. The cells were then stained for gp150, an abundant virion glycoprotein, with mAb LS-B11 (IgG1) and
for ORF65 capsid with mAb MG-12B8 (IgG2a). Nuclei were counterstained with DAPI.
doi:10.1371/journal.pone.0002811.g004
MuHV-4 gH
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staining (pre-fusion) was weaker on cells infected with gL knockout
viruses than with wild-type or revertant viruses, and MG-1A12
staining (post-fusion) was stronger. Thus, the premature capsid
release of gL
2 virions reflected gH being in its down-stream gH-
only form from the start, and gB engaging prematurely in
membrane fusion after endocytosis.
gL deficiency compromises host entry
A key point with MuHV-4 is that in vitro molecular deficits can
be linked to in vivo host colonization phenotypes. We have shown
before that MuHV-4 gL knockouts colonize mice remarkably
normally after intranasal inoculation of 10
4 plaque-forming units
[20]. However, the in vitro entry deficit of gL
2 virions (Fig. 3)
suggested that initial host entry might be impaired. Since host
colonization by MuHV-4 is relatively dose-independent [24], such
a deficit might not be apparent except at very low inoculation
doses. We therefore compared gL
2 (2 independent mutants) and
gL
+ (revertant and wild-type) viruses for their capacity to establish
infection after intranasal inoculation of 1–100 p.f.u. (Table 1). gL
disruption reduced significantly the rate of infection after low dose
inoculation. Thus, while gL deficiency has little impact on MuHV-
4 intra-host spread, it compromised severely the efficiency with
which cell-free virions first entered naive hosts.
Discussion
Sheer complexity has made herpesvirus membrane fusion hard
to unravel, for example Herpes simplex virus can undergo
endosomal or plasma membrane fusion in different cell types
[25]. However, the underlying molecular events are likely to be
similar. Endocytic entry is easier to dissect because binding and
fusion remain anatomically distinct. MuHV-4 capsid release after
endocytic entry was associated with conformation switches in both
gB and gH. Low pH was a key trigger of these switches and gL was
a key negative regulator. Thus, by associating with newly
synthesized gH in the endoplasmic reticulum gL sets virions for
cell binding, and by dissociating again in late endosomes of the
next cell it triggers membrane fusion.
Analogy with the Vesicular stomatitis virus glycoprotein G
[15,16] would suggest that the conformation changes in the
MuHV-4 gB are intrinsic to its fusion mechanism, with the stable
BN-1A7
+ or MG-1A12
+ forms representing the respective pre-
and post-fusion states. This general model does not apply so easily
to gH (gH/gL being pre-fusion and gH-only post-fusion), as gL
2
virions fail to express gH/gL yet fuse more readily than the wild-
type rather than less. It is possible that gL
2 virions express
another, as yet unidentified, pre-fusion form of gH. However, we
have found no antigenic evidence of other forms (data not shown).
Our working hypothesis is therefore that gH/gL and gH-only are
both pre-fusion - gH/gL being up-stream of gH-only - and that
further gH conformation changes accompany fusion itself. In
support of this, gH-only epitopes tended to disappear after a 4 h
37uC incubation, whereas MG-1A12-type gB epitopes were
maintained (data not shown). Thus, gL dissociation from gH
appears to prime gH for membrane fusion rather than being a part
of the fusion reaction per se.
A pre-fusion conformation change cannot be ruled out for gB
either. Heldwein et al. [15] proposed that their gB conformation -
which is probably a down-stream form [26] - undergoes further
changes to reveal fusion loops. The neutralization epitopes
mapped onto this structure [15] would also be difficult to explain
if it were simply a post-fusion form. Thus, although the default
explanation has to be that gB functions like the Vesicular
stomatitis virus glycoprotein G because of their structural
homology, it is also possible that the herpesvirus membrane
fusion mechanism is different. gB and gH conformation changes
must drive fusion, but this does not necessarily mean that every
conformation change is part of the fusion mechanism. It is possible
that the conformation changes described for Vesicular stomatits
virus have for herpesviruses acquired a different function. But
whatever the precise fusion mechanism of herpesviruses, a central
role for the MuHV-4 gL in stabilizing gH and gB against engaging
in fusion seemed clear.
The influence of gL on the conformation of gB was presumably
indirect. A loss of gL would change gH/gL to gH-only and would
therefore disrupt the interaction [27] between gH/gL and the gB
N-terminus (gB-NT). This would not separate gH from gB, since
their association is independent of both gL [21] and gB-NT [27],
but could promote a conformation change in the gB extracellular
domain. Consistent with such a scheme, MuHV-4 lacking gB-NT
shows a gB conformational instability much like that of gL
2
mutants [27]. The gB-NT-gH/gL interaction does not appear to
Figure 5. gL-deficient MuHV-4 remains dependent on endocy-
tosis and lysosomal acidification. BHK-21 cells were treated as
indicated for 2 h, then infected with gL- (gL
2DEL, gL
2DEL-STOP) or gL
+
(wild-type, revertant) MuHV-4 (1 p.f.u./cell). Drug treatment was
maintained throughout the course of infection. Infection rates were
determined by flow cytometric assay of viral eGFP expression after 18 h.
Each point shows the result for 10,000 cells. Equivalent results were
obtained in a repeat experiment.
doi:10.1371/journal.pone.0002811.g005
MuHV-4 gH
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mutants maintain gH/gL expression and infect normally [27].
Therefore the gB conformation change alone is not sufficient for
fusion: gL rather than gB-NT is the key fusion regulator. We
envisage that the late endosomal milieu disrupts the gH/gL
interaction, with low pH playing an important permissive role; gH
then changes its conformation to allow hemi-fusion [28] and
displace gB-NT; this then allows gB to switch to its pro-fusion form
and complete the fusion reaction. In this way, the whole of
membrane fusion can be regulated by gL. The neatness of this
mechanism for regulating virion entry suggests that it will prove
common to many herpesviruses.
Materials and Methods
Cells, viruses, mice
BHK-21 fibroblasts, NIH-3T3 fibroblasts, NMuMG epithelial
cells, and MCCD epithelial cells were propagated as described
[27]. Wild-type and gL
2 viruses were derived from a cloned
MuHV-4 BAC [29] and grown in BHK-21 cells [29]. Female
BALB/c mice (Harlan, Bicester, U.K.), were infected intranasally
with MuHV-4 under general anaesthesia when 6–8 weeks old, in
accordance with the animal care guidelines of Home Office
Project Licence 80/1992 [30]. For virus titrations, lungs were
removed post-mortem, freeze-thawed, and homogenized in 1 ml
PBS. Serial dilutions were then plated onto BHK-21 cell
monolayers. These were fixed with 4% formaldehyde after 4 days
and stained with 0.1% toluidine blue for plaque counting [30].
Immunofluorescence
Cells on glass coverslips [31] were exposed to MuHV-4 virions
(3 p.f.u./cell) to allow binding, in most experiments at 4uC. The
cells were then washed63 in PBS to remove unbound virions and
shifted to 37uC to allow endocytosis. They were fixed in 4%
paraformaldehyde (30 min) either before or after endocytosis, then
permeabilized with 0.1% Triton X-100. Where indicated,
bafilomycin, concanamycin A, NH4Cl or chlorpromazine was
added from 2 h pre-infection to the time of fixation. Viral
glycoproteins were detected with murine mAbs (Table 2) at 1–
10 mg/ml plus Alexa488- or Alexa568-labeled anti-mouse IgG
(Invitrogen, Paisley, U.K.) or Alexa488- or Alexa633- labeled anti-
mouse IgG1 plus Alexa568- labeled anti-mouse IgG2a at 1 mg/ml.
LAMP-1 was detected with mAb 104B (BD-Pharmingen, Oxford,
U.K.) plus Alexa488- or Alexa568- labeled anti-rat IgG (Invitro-
gen). Nuclei were counterstained with DAPI. Fluorescence was
visualized on a Leica SP2 confocal microscope.
Figure 6. gL-deficient virions show abnormal entry in NIH-3T3 fibroblasts. gL
+ and gL
2 virions were bound to adherent NIH-3T3 cells (2 h,
4uC). Unbound virions were then removed by PBS wash. The cells were then either fixed (4uC) or first incubated (2 h, 37uC) to allow virion endocytosis
and then fixed (37uC). All cells were then permeabilized and stained for MuHV-4 virion components (green) and LAMP-1 (red) as shown. Nuclei were
counter-stained with DAPI (blue). In the absence of gL, both capsids and glycoproteins remained peripheral. gB conformation changes were also
affected. Notably, MG-1A12
+ gB appeared in peripheral, LAMP-1
2 endosomes. Representative cells are shown.
doi:10.1371/journal.pone.0002811.g006
Figure 7. gL-dependent gB conformational instability in MuHV-
4-infected BHK-21 cells. BHK-21 cells were left uninfected (UI) or
infected with gL
2 (gL
2STOP, gL
2DEL) or gL
+ (wild-type, gL
2DEL
revertant) viruses (2 p.f.u./cell, 18 h). The cells were then trypsinized
and stained with secondary antibody only (nil, solid lines) or for gN
(mAb 3F7, dotted lines), gH-only (mAb MG-9B10, solid lines), gH/gL
(mAb T2C12, dotted lines), the mAb BN-1A7
+ virion gB conformation
(gB vir, dotted lines) or the mAb MG-1A12
+ pro-fusion gB conformation
(gB fus, solid lines). The data are from 1 of 3 equivalent experiments.
doi:10.1371/journal.pone.0002811.g007
Table 1. Low dose in vivo infection by gL
+ and gL
2 MuHV-4.
infecting dose
virus 1 p.f.u. 10 p.f.u. 100 p.f.u.
wild-type 6/12
1 12/12 12/12
gL
2DEL 1/15 7/12 10/12
gL
2STOP 2/15 7/12 10/12
revertant 4/12 12/12 12/12
1infected mice/total exposed.
Mice were infected significantly better by wild-type MuHV-4 than by either the
gL
2DEL or gL
2STOP mutants at 10 p.f.u./mouse (p,0.02 by Fisher’s exact test)
and 1 p.f.u./mouse (p,0.05). The revertant was not significantly different to
wild-type. Comparison between 1 p.f.u. and 10 p.f.u. suggested that the in vivo
infectivity of gL knockout virions is about 1/10 that of the wild-type.
doi:10.1371/journal.pone.0002811.t001
Table 2. MAbs used in this study.
MAb Target Isotype Epitope
1
BN-1A7 gB IgG2a conformational
MG-1A12 gB IgG2a conformational
LS-B11 gp150 IgG1 linear
7E5 gH/gL IgG2a conformational
T2C12 gH/gL IgG2a conformational
MG-9B10 gH IgG2b conformational
3F7 gN IgG2a linear
MG-12B8 ORF65 (capsid) IgG2a linear
1As defined by recognition or not of denatured protein on immunoblots.
doi:10.1371/journal.pone.0002811.t002
MuHV-4 gH
PLoS ONE | www.plosone.org 8 July 2008 | Volume 3 | Issue 7 | e2811Flow cytometry
BHK-21 cells were infected with gL
+ or gL
2 MuHV-4 (2–
5 p.f.u./cell), then trypsinized and either analyzed directly for viral
eGFP expression (FACSCalibur, BD Biosciences) or first stained
(1 h, 4uC) with MuHV-4 glycoprotein-specific mAbs plus
fluorescein-labeled anti-mouse IgG (Dako Cytomation) [32].
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